Showing results (11-20 of 54) with videos related to
Sort By:
Pageof 6
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentFernando Goni, Ding Wang, Jianina Suazo, et al.Human Molecular Genetics|December 23, 2020
SPEG binds with desmin and its deficiency causes defects in triad and focal adhesion proteinsShiyu Luo, Qifei Li, Jasmine Lin, et al.Current Problems in Diagnostic Radiology|June 21, 2020
Advertise Right by Addressing the Concerns: An Evaluation of Women's/Breast Imaging Radiology Fellowship Website Content for Prospective FellowsMuhammad Umer Nasir, Nicolas Murray, Shobhit Mathur, et al.Chemical Research in Toxicology|September 10, 2010
Bioactivation of isothiazoles: minimizing the risk of potential toxicity in drug discoveryYohannes Teffera, Deborah Choquette, Jingzhou Liu, et al.Journal of Personalized Medicine|December 24, 2021
Reanalysis of Exome Data Identifies Novel <i>SLC25A46</i> Variants Associated with Leigh SyndromeQifei Li, Jill A Madden, Jasmine Lin, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|October 31, 2009
Relationship between passive permeability, efflux, and predictability of clearance from in vitro metabolic intrinsic clearanceLiyue Huang, Loren Berry, Sindhura Ganga, et al.Biorxiv : the Preprint Server for Biology|October 31, 2023
Genetic deficiency of ribosomal rescue factor HBS1L causes retinal dystrophy associated with Pelota and EDF1 depletionShiyu Luo, Bilal Alwattar, Qifei Li, et al.Disease Models & Mechanisms|July 5, 2024
HBS1L deficiency causes retinal dystrophy in a child and in a mouse model associated with defective development of photoreceptor cellsShiyu Luo, Bilal Alwattar, Qifei Li, et al.Clinica Chimica Acta; International Journal of Clinical Chemistry|June 9, 2024
The solute carrier family 26 member 9 modifies rapidly progressing cystic fibrosis associated with homozygous F508del CFTR mutationShiyu Luo, Stuart Rollins, Klaus Schmitz-Abe, et al.Xenobiotica; the Fate of Foreign Compounds in Biological Systems|February 8, 2011
In vitro and in vivo pharmacokinetic characterizations of AMG 900, an orally bioavailable small molecule inhibitor of aurora kinasesLiyue Huang, Xuhai Be, Loren Berry, et al.Pageof 6